Skip to content
eHealthTutorial — Research Peptide Reviews
Experimental peptide • No established clinical use

AED peptide cell-culture research

Cartalax

Cartalax is a name used for the short AED peptide in research catalogs. A direct published experiment examined chondrogenic markers in cultured human stem cells, not cartilage repair in patients.

Open calculator Explore the research
Generic research visual — not a commercial product
Compound typeShort AED (Ala-Glu-Asp) peptide
Evidence baseNarrow in-vitro cell-culture evidence
Regulatory contextExperimental / No established clinical indication
Page purposeResearch and calculation

Compound calculator

Cartalax reconstitution calculator

Enter the values printed on your vial and the liquid volume you added to calculate concentration, liquid volume, and the corresponding mark on a U-100 syringe scale.

Selected peptide or compoundCartalax
Enter the total amount printed on the vial.
mL
Enter the liquid volume added in milliliters.
You provide this amount; the calculator does not select or recommend it.
Scale reference only; confirm the markings on the physical syringe.

Your Cartalax calculation appears here

Enter the three required values to see the mathematical result.

This calculator performs arithmetic using values you enter. It does not select or recommend an amount, schedule, treatment, preparation method, or method of administration.

Research overview

What is Cartalax?

In this literature the peptide is designated AED, shorthand for the alanine–glutamate–aspartate sequence. Some research catalogs call it Cartalax. A PubMed-indexed paper studied AED alongside a cartilage polypeptide complex in cultured human mesenchymal stem cells. Those two test substances are different, and their findings should not be merged.

What has research examined?

In one published laboratory experiment, the researchers examined gene expression and protein synthesis of SOX9, aggrecan, type II collagen, and COMP in cultured human mesenchymal stem cells undergoing replicative aging. They reported increased expression of those chondrogenic markers under the studied AED cell-culture conditions. The paper proposes further osteoarthritis-model research; it did not demonstrate regenerated human cartilage, patient outcomes, or a validated Cartalax product.

Important limitation

A cell-culture marker response is not clinical efficacy. The name Cartalax on a vial does not independently establish AED sequence, concentration, or equivalence to the tested material. There is no established human or animal treatment, preparation, or use supported by this narrow record.

Research references

Calculation boundary

The calculator performs concentration arithmetic only when a user enters a mass and liquid volume. It does not verify identity, formulation, purity, sterility, stability, compatibility, biological-unit equivalence, or whether reconstitution applies to a particular product. Do not convert IU or other biological units to mg without an authoritative, exact-product relationship.

For research purposes only. This page is educational and is not medical or veterinary advice or a recommendation to purchase, prepare, administer, or use any product.